Core Insights - The A-share market has shown positive momentum at the beginning of 2026, prompting public funds to accelerate their investment strategies, with over ten public institutions resuming large-scale subscriptions for more than ten actively managed equity funds, many of which have seen net value growth exceeding 40% in the past year [1][2] Group 1: Fund Subscription Adjustments - Multiple high-performing equity funds have relaxed their subscription limits at the start of the year, with Penghua Fund announcing the resumption of large subscriptions for its Penghua Dynamic Growth Mixed Fund starting January 12, 2026, lifting the previous daily subscription cap of 1 million yuan [2] - Prior to this, Xinda Australia Fund had already adjusted its subscription rules on January 6, 2026, removing limits for institutional investors on its Xinao Medical Health Mixed A Fund, which previously had a daily subscription limit of 5 million yuan [2] - A total of over ten equity funds have resumed large subscriptions since the beginning of the year, with daily subscription limits ranging from 1 million to 50 million yuan, catering to various funding needs [2][3] Group 2: Performance and Market Outlook - The funds that have recently resumed large subscriptions generally exhibit strong performance, with several products reporting net value growth rates exceeding 40% over the past year, including the Xinao Medical Health Mixed A Fund, which achieved a remarkable 70.04% growth [3] - The chief economist of Qianhai Kaiyuan Fund indicated that the decision to relax subscription limits is based on confidence in performance and market opportunities, as A-share valuations are considered reasonable, supported by policy backing and economic recovery expectations [3] Group 3: Market Dynamics and Fund Strategy - The simultaneous relaxation of subscription limits is influenced by multiple factors, including the completion of year-end settlements by institutions like insurance companies, which opens a window for long-term capital allocation [4] - The expectation of a "spring rally" in the A-share market is increasing, enhancing the willingness of funds to attract new capital, while the relaxation of limits aligns with the marketing strategies of banks at the beginning of the year [4] - Industry experts suggest that the relaxation of subscription limits sends a positive signal to the market, with structural opportunities in sectors related to technology and high-end manufacturing expected to become core investment directions for funds [4]

Group 1: Market Overview - The Hong Kong stock market is experiencing a recovery with innovative pharmaceuticals and internet platforms leading the gains, as institutional investors continue to seek structural opportunities in 2026 [1] - After two years of valuation compression, the overall Hong Kong stock market is at historical lows, with innovative drug pipelines entering a harvest phase and platform-based internet companies showing stable cash flows [1] - High-dividend central enterprise assets are highlighted for their defensive characteristics, suggesting that these three categories of stocks are likely to benefit from profit upgrades and capital inflows [1] Group 2: Fund News - On January 8, 12 new funds were launched, primarily mixed and equity funds, with the招商中证有色金属矿业主题ETF联接A aiming to raise 3 billion yuan [2] - A total of 11 funds announced dividends, with the华富天鑫灵活配置混合型证券投资基金 distributing the highest dividend of 0.5000 yuan per 10 fund shares [2] - In early 2026, 19 public funds, including华商, 银河, and泰康, launched fee reductions, indicating a shift from scale-driven to quality competition in the industry [2] Group 3: Fund Dividends - The华富天鑫灵活配置混合A fund will distribute a dividend of 0.5000 yuan per 10 shares on January 9, 2026 [4] - The安信永鑫增强债券A and C funds will each distribute a dividend of 0.0500 yuan per 10 shares on the same date [4] - The华泰柏瑞中证红利低波ETF联接 funds will also distribute dividends of 0.0500 yuan per 10 shares on January 9, 2026 [4]

Group 1 - The article provides an overview of the latest net asset values of various funds, highlighting the top-performing and bottom-performing funds as of December 16, 2025 [2][3] - The top 10 funds with the highest net value growth include Dongcai Economic Growth C, Dongcai Economic Growth A, and Green Innovation Growth A, among others, with growth rates ranging from 1.31% to 1.90% [2] - The bottom 10 funds with the lowest net value growth include Yongying Manufacturing Upgrade C and A, with declines of -6.25%, and other funds experiencing declines between -4.72% and -5.35% [3] Group 2 - The market analysis indicates a downward trend in the Shanghai Composite Index, with a trading volume of 1.74 trillion, and a significant number of stocks declining compared to those that rose [5] - Leading sectors include public transportation and hotel catering, which saw increases of over 2%, while mineral products and shipbuilding sectors experienced declines exceeding 3% [5] - The fund with the fastest net value growth is identified as Dongcai Economic Growth C, reflecting a strong performance in the current market conditions [5] Group 3 - The top holdings of the funds show a concentration in specific stocks, with the top 10 holdings accounting for 23.46% of the total portfolio in one fund, indicating a focused investment strategy [6] - Conversely, another fund's top 10 holdings represent 65.84% of its total portfolio, with significant declines in stocks like Hezhu Intelligent and Yongding Shares, suggesting a riskier investment profile [6] - The performance of these funds is influenced by their sector focus, with one fund leaning towards the electric power industry and another towards the North Exchange concept, impacting their relative market performance [6]

Core Insights - The article provides an overview of the performance of various mutual funds, highlighting the top and bottom performers based on net asset value changes [1] Group 1: Top Performing Funds - The top 10 mutual funds with the highest net value growth include: 1. 德邦新兴产业混合发起式A with a growth of 6.45% 2. 德邦新兴产业混合发起式C with a growth of 6.44% 3. 东方低碳经济混合A with a growth of 6.27% 4. 东方低碳经济混合C with a growth of 6.27% 5. 富荣福鑫混合A with a growth of 6.12% 6. 富荣福鑫混合C with a growth of 6.11% 7. 同泰新能源1年持有股票C with a growth of 5.81% 8. 同泰新能源1年持有股票A with a growth of 5.81% 9. 华富天鑫灵活配置混合A with a growth of 5.19% 10. 华富天鑫灵活配置混合C with a growth of 5.18% [2] Group 2: Bottom Performing Funds - The bottom 10 mutual funds with the lowest net value growth include: 1. 德邦乐享生活混合A with a decline of 3.28% 2. 德邦乐享生活混合C with a decline of 3.27% 3. 泰信发展主题混合 with a decline of 2.51% 4. 东方阿尔法瑞享混合发起C with a decline of 2.19% 5. 东方阿尔法瑞享混合发起A with a decline of 2.19% 6. 中欧制造升级混合发起C with a decline of 1.90% 7. 中欧制造升级混合发起A with a decline of 1.90% 8. 易方达优势回报混合(FOF-LOF)C with a decline of 1.77% 9. 易方达优势回报混合(FOF-LOF)A with a decline of 1.76% 10. 泰信现代服务业混合 with a decline of 1.74% [3] Group 3: Market Overview - The Shanghai Composite Index opened lower but rebounded, closing with a small gain, while the ChiNext Index experienced a similar pattern. The total trading volume reached 2.11 trillion yuan, with a market breadth of 2,683 gainers to 2,612 losers [5] - Leading sectors included non-ferrous metals, engineering machinery, electrical equipment, and semiconductors, while lagging sectors included commercial retail, public transportation, and oil [5]

Core Insights - Aikaisibo Electric Co., Ltd. experienced a 5% increase in stock price, reaching 44.50 CNY per share, with a trading volume of 118 million CNY and a turnover rate of 3.07%, resulting in a total market capitalization of 5.135 billion CNY [1] Company Overview - Aikaisibo Electric Co., Ltd. is located in Xi'an, Shaanxi Province, established on January 19, 1996, and listed on September 28, 2023. The company specializes in the research, production, and sales of power electronic conversion and control equipment [1] - The revenue composition of the company includes: precision testing power supply (62.98%), power quality control equipment (17.25%), special power supply (16.85%), and other (2.74%) [1] Fund Holdings - Huafu Fund has a significant holding in Aikaisibo, with the Huafu Tianxin Flexible Allocation Mixed A Fund (003152) holding 54,100 shares, accounting for 6.74% of the fund's net value, making it the third-largest holding. The estimated floating profit today is approximately 114,700 CNY [2] - The Huafu Tianxin Flexible Allocation Mixed A Fund was established on December 29, 2016, with a latest scale of 24.745 million CNY. Year-to-date returns are 26.52%, ranking 3728 out of 8234 in its category, while the one-year return is 29.44%, ranking 2943 out of 8083. Since inception, the fund has achieved a return of 104.64% [2]

Core Viewpoint - Fund manager Chen Qiming has managed two funds as of the end of Q2 2025, with the best-performing fund being Huafu Tianxin Flexible Allocation Mixed A (003152), which achieved a net value increase of 0.92% in the quarter [1]. Fund Performance Summary - Chen Qiming's managed funds include: - Huafu Dacai Flexible Allocation Mixed C (003153) with an annualized return of 5.68% and a Q2 increase of 0.70%, holding a major stock, Xuguang Electronics (600353.SH), at 7.23% of net value [2]. - Huafu Daxin Flexible Allocation Mixed A (003152) with an annualized return of 6.53% and a Q2 increase of 0.92%, also holding Xuguang Electronics at 7.23% of net value [2]. - During his tenure managing Huafu Value Growth Mixed A (410007), Chen achieved a cumulative return of 232.74% with an average annualized return of 11.77%, executing 96 stock adjustments with a success rate of 63.54% [2]. Stock Adjustment Cases - Notable stock adjustment cases managed by Chen Qiming include: - Boteng Co., Ltd. (300363) was bought in Q2 2018 and sold in Q3 2022, yielding an estimated return of 396.40% with a company performance growth of 1510.87% during the holding period [5]. - Yifeng Pharmacy (603939) was bought in Q2 2016 and sold in Q2 2019, yielding an estimated return of 96.12% with a company performance growth of 175.23% during the holding period [6]. - Beilu Pharmaceutical (300016) was bought in Q2 2015 and sold in Q1 2017, resulting in a loss of -59.25% despite a company performance growth of 264.70% during the holding period [7].